Profiling of hepatic gene expression in rats treated with fibric acid analogs

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 549, Issue 1-2, 2004, Pages 131-145

  Cornwell, Paul D ^a   De Souza, Angus T ^a   Ulrich, Roger G ^a  

^a ROSETTA INPHARMATICS   (United States)

Author keywords

Expression profiling; Fenofibrate; Liver; Peroxisome proliferators; Peroxisome proliferator activated receptor ; Rat

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FATTY ACID; FIBRIC ACID DERIVATIVE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRIACYLGLYCEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; ENZYME ACTIVITY; GENE EXPRESSION PROFILING; GLUCONEOGENESIS; GLUCOSE TRANSPORT; GLYCOLYSIS; HISTOPATHOLOGY; LIVER; LIVER CELL DAMAGE; LIVER HYPERTROPHY; LIVER METABOLISM; LIVER TOXICITY; LOW DRUG DOSE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; RNA ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; UNINDEXED SEQUENCE;

ANIMALS; BODY WEIGHT; GENE EXPRESSION PROFILING; LIVER; MALE; ORGAN SIZE; PROCETOFEN; RATS;

RODENTIA;

EID: 2142810109     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2003.12.019     Document Type: Article

References (62)

1. Bradford R.H., Goldberg A.C., Schonfeld G., Knopp R.H. Double-blind comparison of bezafibrate versus placebo in male volunteers with hyperlipoproteinemia. Atherosclerosis. 92:1992;31-40
2. Guo Q., Wang P.R., Milot D.P., Ippolito M.C., Hernandez M., Burton C.A., Wright S.D., Chao Y. Regulation of lipid metabolism and gene expression by fenofibrate in hamsters. Biochim. Biophys. Acta. 1533:2001;220-232
3. Blane G.F. Review of European clinical experience with fenofibrate. Cardiology. 76(Suppl. 1):1989;1-13
4. Schoonjans K., Staels B., Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res. 37:1996;907-925
5. Schoonjans K., Staels B., Auwerx J. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta. 1302:1996;93-109
6. Gonzalez F.J., Peters J.M., Cattley R.C. Mechanism of action of the nongenotoxic peroxisome proliferators: role of the peroxisome proliferator-activator receptor alpha. J. Natl. Cancer Inst. 90:1998;1702-1709
7. Kliewer S.A., Sundseth S.S., Jones S.A., Brown P.J., Wisely G.B., Koble C.S., Devchand P., Wahli W., Willson T.M., Lenhard J.M., Lehmann J.M. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc. Natl. Acad. Sci. U.S.A. 94:1997;4318-4323
8. Forman B.M., Chen J., Evans R.M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc. Natl. Acad. Sci. U.S.A. 94:1997;4312-4317
9. Flatmark T., Nilsson A., Kvannes J., Eikhom T.S., Fukami M.H., Kryvi H., Christiansen E.N. On the mechanism of induction of the enzyme systems for peroxisomal beta-oxidation of fatty acids in rat liver by diets rich in partially hydrogenated fish oil. Biochim. Biophys. Acta. 962:1988;122-130
10. Willumsen N., Hexeberg S., Skorve J., Lundquist M., Berge R.K. Docosahexaenoic acid shows no triglyceride-lowering effects but increases the peroxisomal fatty acid oxidation in liver of rats. J. Lipid Res. 34:1993;13-22
11. De Craemer D., Vamecq J., Roels F., Vallee L., Pauwels M., Van den Branden C. Peroxisomes in liver, heart, and kidney of mice fed a commercial fish oil preparation: original data and review on peroxisomal changes induced by high-fat diets. J. Lipid Res. 35:1994;1241-1250
12. Kramer J.A., Blomme E.A., Bunch R.T., Davila J.C., Jackson C.J., Jones P.F., Kolaja K.L., Curtiss S.W. Transcription profiling distinguishes dose-dependent effects in the livers of rats treated with clofibrate. Toxicol. Pathol. 31:2003;417-431
13. Lee S.S., Pineau T., Drago J., Lee E.J., Owens J.W., Kroetz D.L., Fernandez-Salguero P.M., Westphal H., Gonzalez F.J. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15:1995;3012-3022
14. Reddy J.K., Scarpelli D.G., Subbarao V., Lalwani N.D. Chemical carcinogens without mutagenic activity: peroxisome proliferators as a prototype. Toxicol. Pathol. 11:1983;172-180
15. Reddy J.K., Azarnoff D.L., Hignite C.E. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature. 283:1980;397-398
16. Peters J.M., Cattley R.C., Gonzalez F.J. Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14, 643. Carcinogenesis. 18:1997;2029-2033
17. Gonzalez F. The peroxisome proliferator-activated receptor alpha (PPARalpha): role in hepatocarcinogenesis. Mol. Cell. Endocrinol. 193:2002;71
18. National Research Council, The Guide for the Care and Use of Laboratory Animals, National Academy Press, Washington, DC, 1996.
19. Hughes T.R., Mao M., Jones A.R., Burchard J., Marton M.J., Shannon K.W., Lefkowitz S.M., Ziman M., Schelter J.M., Meyer M.R., Kobayashi S., Davis C., Dai H., He Y.D., Stephaniants S.B., Cavet G., Walker W.L., West A., Coffey E., Shoemaker D.D., Stoughton R., Blanchard A.P., Friend S.H., Linsley P.S. Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. Nat. Biotechnol. 19:2001;342-347
20. Waring J.F., Cavet G., Jolly R.A., McDowell J., Dai H., Ciurlionis R., Zhang C., Stoughton R., Lum P., Ferguson A., Roberts C.J., Ulrich R.G. Development of a DNA microarray for toxicology based on hepatotoxin-regulated sequences. Environ. Health Perspect. 111:2003;863-870
21. Marton M.J., DeRisi J.L., Bennett H.A., Iyer V.R., Meyer M.R., Roberts C.J., Stoughton R., Burchard J., Slade D., Dai H., Bassett D.E. Jr., Hartwell L.H., Brown P.O., Friend S.H. Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat. Med. 4:1998;1293-1301
22. Kritchevsky D., Tepper S.A., Story J.A. Influence of procetofen on lipid metabolism in normocholesteremic rats. Pharmacol. Res. Commun. 11:1979;635-641
23. Haubenwallner S., Essenburg A.D., Barnett B.C., Pape M.E., DeMattos R.B., Krause B.R., Minton L.L., Auerbach B.J., Newton R.S., Leff T., et al. Hypolipidemic activity of select fibrates correlates to changes in hepatic apolipoprotein C-III expression: a potential physiologic basis for their mode of action. J. Lipid Res. 36:1995;2541-2551
24. Lussier-Cacan S., Bard J.M., Boulet L., Nestruck A.C., Grothe A.M., Fruchart J.C., Davignon J. Lipoprotein composition changes induced by fenofibrate in dysbetalipoproteinemia type III. Atherosclerosis. 78:1989;167-182
25. Bard J.M., Parra H.J., Camare R., Luc G., Ziegler O., Dachet C., Bruckert E., Douste-Blazy P., Drouin P., Jacotot B., et al. A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein composition. Metabolism. 41:1992;498-503
26. Staels B., Vu-Dac N., Kosykh V.A., Saladin R., Fruchart J.C., Dallongeville J., Auwerx J. Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates. J. Clin. Invest. 95:1995;705-712
27. Hertz R., Bishara-Shieban J., Bar-Tana J. Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III. J. Biol. Chem. 270:1995;13470-13475
28. Wang C.S., McConathy W.J., Kloer H.U., Alaupovic P. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J. Clin. Invest. 75:1985;384-390
29. A.L. Lehninger, D.L. Nelson, M.M. Cox, Principles of Biochemistry, Worth, New York, 1993.
30. Staels B., Auwerx J. Perturbation of developmental gene expression in rat liver by fibric acid derivatives: lipoprotein lipase and alpha-fetoprotein as models. Development. 115:1992;1035-1043
31. Schoonjans K., Peinado-Onsurbe J., Lefebvre A.M., Heyman R.A., Briggs M., Deeb S., Staels B., Auwerx J. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J. 15:1996;5336-5348
32. Martin G., Schoonjans K., Lefebvre A.M., Staels B., Auwerx J. Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators. J. Biol. Chem. 272:1997;28210-28217
33. Schoonjans K., Watanabe M., Suzuki H., Mahfoudi A., Krey G., Wahli W., Grimaldi P., Staels B., Yamamoto T., Auwerx J. Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter. J. Biol. Chem. 270:1995;19269-19276
34. Schoonjans K., Staels B., Grimaldi P., Auwerx J. Acyl-CoA synthetase mRNA expression is controlled by fibric-acid derivatives. Eur. J. Biochem. 216:1993;615-622
35. Boeckmann B., Bairoch A., Apweiler R., Blatter M.C., Estreicher A., Gasteiger E., Martin M.J., Michoud K., O'Donovan C., Phan I., Pilbout S., Schneider M. The SWISS-PROT protein knowledge base and its supplement TrEMBL in 2003. Nucl. Acids Res. 31:2003;365-370
36. Lee H.J., Choi S.S., Park M.K., An Y.J., Seo S.Y., Kim M.C., Hong S.H., Hwang T.H., Kang D.Y., Garber A.J., Kim D.K. Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats. Biochem. Biophys. Res. Commun. 296:2002;293-299
37. Elcombe C.R., Mitchell A.M. Peroxisome proliferation due to di(2-ethylhexyl) phthalate (DEHP): species differences and possible mechanisms. Environ. Health Perspect. 70:1986;211-219
38. Foxworthy P.S., Eacho P.I. Inhibition of hepatic fatty acid oxidation at carnitine palmitoyltransferase I by the peroxisome proliferator 2-hydroxy-3-propyl-4-[6-(tetrazol-5-yl) hexyloxy]acetophenone. Biochem. J. 252:1988;409-414
39. Foxworthy P.S., Perry D.N., Hoover D.M., Eacho P.I. Changes in hepatic lipid metabolism associated with lipid accumulation and its reversal in rats given the peroxisome proliferator LY171883. Toxicol. Appl. Pharmacol. 106:1990;375-383
40. Kamijo K., Taketani S., Yokota S., Osumi T., Hashimoto T. The 70-kDa peroxisomal membrane protein is a member of the Mdr (P-glycoprotein)-related ATP-binding protein superfamily. J. Biol. Chem. 265:1990;4534-4540
41. Berger J., Albet S., Bentejac M., Netik A., Holzinger A., Roscher A.A., Bugaut M., Forss-Petter S. The four murine peroxisomal ABC-transporter genes differ in constitutive, inducible and developmental expression. Eur. J. Biochem. 265:1999;719-727
42. Albet S., Causeret C., Bentejac M., Mandel J.L., Aubourg P., Maurice B. Fenofibrate differently alters expression of genes encoding ATP-binding transporter proteins of the peroxisomal membrane. FEBS Lett. 405:1997;394-397
43. Fourcade S., Savary S., Albet S., Gauthe D., Gondcaille C., Pineau T., Bellenger J., Bentejac M., Holzinger A., Berger J., Bugaut M. Fibrate induction of the adrenoleukodystrophy-related gene (ABCD2): promoter analysis and role of the peroxisome proliferator-activated receptor PPARalpha. Eur. J. Biochem. 268:2001;3490-3500
44. Tugwood J.D., Issemann I., Anderson R.G., Bundell K.R., McPheat W.L., Green S. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 11:1992;433-439
45. Zhang B., Marcus S.L., Miyata K.S., Subramani S., Capone J.P., Rachubinski R.A. Characterization of protein-DNA interactions within the peroxisome proliferator-responsive element of the rat hydratase-dehydrogenase gene. J. Biol. Chem. 268:1993;12939-12945
46. Zhang B., Marcus S.L., Sajjadi F.G., Alvares K., Reddy J.K., Subramani S., Rachubinski R.A., Capone J.P. Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase. Proc. Natl. Acad. Sci. U.S.A. 89:1992;7541-7545
47. Bardot O., Aldridge T.C., Latruffe N., Green S. PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene. Biochem. Biophys. Res. Commun. 192:1993;37-45
48. Kaikaus R.M., Chan W.K., Lysenko N., Ray R., Ortiz de Montellano P.R., Bass N.M. Induction of peroxisomal fatty acid beta-oxidation and liver fatty acid-binding protein by peroxisome proliferators. Mediation via the cytochrome P-450IVA1 omega-hydroxylase pathway. J. Biol. Chem. 268:1993;9593-9603
49. Sharma R., Lake B.G., Gibson G.G. Co-induction of microsomal cytochrome P-452 and the peroxisomal fatty acid beta-oxidation pathway in the rat by clofibrate and di-(2-ethylhexyl)phthalate. Dose-response studies. Biochem. Pharmacol. 37:1988;1203-1206
50. Kimura S., Hardwick J.P., Kozak C.A., Gonzalez F.J. The rat clofibrate-inducible CYP4A subfamily. II. cDNA sequence of IVA3, mapping of the Cyp4a locus to mouse chromosome 4, and coordinate and tissue-specific regulation of the CYP4A genes. DNA. 8:1989;517-525
51. Bell D.R., Elcombe C.R. Induction of acyl-CoA oxidase and cytochrome P450IVA1 RNA in rat primary hepatocyte culture by peroxisome proliferators. Biochem. J. 280(Pt 1):1991;249-253
52. Bell D.R., Bars R.G., Gibson G.G., Elcombe C.R. Localization and differential induction of cytochrome P450IVA and acyl-CoA oxidase in rat liver. Biochem. J. 275(Pt 1):1991;247-252
53. Mannaerts G.P., Thomas J., Debeer L.J., McGarry J.D., Foster D.W. Hepatic fatty acid oxidation and ketogenesis after clofibrate treatment. Biochim. Biophys. Acta. 529:1978;201-211
54. Naggert J., Witkowski A., Wessa B., Smith S. Expression in Escherichia coli, purification and characterization of two mammalian thioesterases involved in fatty acid synthesis. Biochem. J. 273(Pt 3):1991;787-790
55. Broustas C.G., Larkins L.K., Uhler M.D., Hajra A.K. Molecular cloning and expression of cDNA encoding rat brain cytosolic acyl-coenzyme A thioester hydrolase. J. Biol. Chem. 271:1996;10470-10476
56. Miyazawa S., Furuta S., Hashimoto T. Induction of a novel long-chain acyl-CoA hydrolase in rat liver by administration of peroxisome proliferators. Eur. J. Biochem. 117:1981;425-430
57. Yamada J., Matsumoto I., Furihata T., Sakuma M., Suga T. Purification and properties of long-chain acyl-CoA hydrolases from the liver cytosol of rats treated with peroxisome proliferator. Arch. Biochem. Biophys. 308:1994;118-125
58. Ofman R., el Mrabet L., Dacremont G., Spijer D., Wanders R.J. Demonstration of dimethylnonanoyl-CoA thioesterase activity in rat liver peroxisomes followed by purification and molecular cloning of the thioesterase involved. Biochem. Biophys. Res. Commun. 290:2002;629-634
59. Holness M.J., Bulmer K., Smith N.D., Sugden M.C. Investigation of potential mechanisms regulating protein expression of hepatic pyruvate dehydrogenase kinase isoforms 2 and 4 by fatty acids and thyroid hormone. Biochem. J. 369:2003;687-695
60. Castelein H., Gulick T., Declercq P.E., Mannaerts G.P., Moore D.D., Baes M.I. The peroxisome proliferator activated receptor regulates malic enzyme gene expression. J. Biol. Chem. 269:1994;26754-26758
61. Tontonoz P., Hu E., Devine J., Beale E.G., Spiegelman B.M. PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol. Cell. Biol. 15:1995;351-357
62. Tran H., Brunet A., Grenier J.M., Datta S.R., Fornace A.J. Jr., DiStefano P.S., Chiang L.W., Greenberg M.E. DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science. 296:2002;530-534